Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Amortization of Deferred Charges (2022 - 2025)

Cytokinetics (CYTK) has disclosed Amortization of Deferred Charges for 4 consecutive years, with $14.9 million as the latest value for Q4 2025.

  • Quarterly Amortization of Deferred Charges changed N/A to $14.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.5 million through Dec 2025, changed N/A year-over-year, with the annual reading at $22.9 million for FY2025, 98.12% up from the prior year.
  • Amortization of Deferred Charges for Q4 2025 was $14.9 million at Cytokinetics, up from $3.5 million in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $14.9 million in Q4 2025, with the low at -$13.6 million in Q4 2023.
  • Average Amortization of Deferred Charges over 4 years is $3.0 million, with a median of $2.7 million recorded in 2024.
  • Peak annual rise in Amortization of Deferred Charges hit 429.85% in 2023, while the deepest fall reached 1350.83% in 2023.
  • Over 4 years, Amortization of Deferred Charges stood at $1.1 million in 2022, then crashed by 1350.83% to -$13.6 million in 2023, then skyrocketed by 125.62% to $3.5 million in 2024, then soared by 326.68% to $14.9 million in 2025.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $14.9 million, $3.5 million, and $3.5 million for Q4 2025, Q1 2025, and Q3 2024 respectively.